179 related articles for article (PubMed ID: 8706307)
1. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours.
Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N
Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307
[TBL] [Abstract][Full Text] [Related]
2. Inhibin forms in serum from postmenopausal women with ovarian cancers.
Robertson DM; Cahir N; Burger HG; Mamers P; Groome N
Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065
[TBL] [Abstract][Full Text] [Related]
3. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
[TBL] [Abstract][Full Text] [Related]
5. Inhibin as a marker for ovarian cancer.
Cooke I; O'Brien M; Charnock FM; Groome N; Ganesan TS
Br J Cancer; 1995 May; 71(5):1046-50. PubMed ID: 7734297
[TBL] [Abstract][Full Text] [Related]
6. [Inhibin and ovarian cancer].
Burger HG; Baillie A; Drummond AE; Healy DL; Jobling T; Mamers P; Robertson DM; Susil B; Cahir N; Shen Y; Verity K; Fuller PJ; Groome NP; Findlay JK
Vopr Onkol; 1999; 45(4):369-73. PubMed ID: 10532093
[TBL] [Abstract][Full Text] [Related]
7. Combined inhibin and CA125 assays in the detection of ovarian cancer.
Robertson DM; Cahir N; Burger HG; Mamers P; McCloud PI; Pettersson K; McGuckin M
Clin Chem; 1999 May; 45(5):651-8. PubMed ID: 10222351
[TBL] [Abstract][Full Text] [Related]
8. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women.
Burger HG; Cahir N; Robertson DM; Groome NP; Dudley E; Green A; Dennerstein L
Clin Endocrinol (Oxf); 1998 Jun; 48(6):809-13. PubMed ID: 9713572
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathophysiological aspects of inhibin.
Healy DL; Mamers P; Bangah M; Burger HG
Hum Reprod; 1993 Nov; 8 Suppl 2():138-40. PubMed ID: 8276948
[TBL] [Abstract][Full Text] [Related]
10. The inhibins and ovarian cancer.
Burger HG; Fuller PJ; Chu S; Mamers P; Drummond A; Susil B; Neva P; Robertson DM
Mol Cell Endocrinol; 2001 Jun; 180(1-2):145-8. PubMed ID: 11451584
[TBL] [Abstract][Full Text] [Related]
11. Total inhibin is a potential serum marker for epithelial ovarian cancer.
Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
[TBL] [Abstract][Full Text] [Related]
12. Serum inhibin and disease status in women with ovarian granulosa cell tumors.
Boggess JF; Soules MR; Goff BA; Greer BE; Cain JM; Tamimi HK
Gynecol Oncol; 1997 Jan; 64(1):64-9. PubMed ID: 8995549
[TBL] [Abstract][Full Text] [Related]
13. Inhibin and ovarian cancer.
Burger HG; Baillie A; Drummond AE; Healy DL; Jobling T; Mamers P; Robertson DM; Susil B; Cahir N; Shen Y; Verity K; Fuller PJ; Groome NP; Findlay JK
J Reprod Immunol; 1998 Aug; 39(1-2):77-87. PubMed ID: 9786454
[TBL] [Abstract][Full Text] [Related]
14. Peripheral vein, ovarian vein and ovarian tissue levels of inhibin in a postmenopausal patient with a granulosa cell tumour.
Sluijmer AV; Heineman MJ; Evers JL; de Jong FH
Acta Endocrinol (Copenh); 1993 Oct; 129(4):311-4. PubMed ID: 8237248
[TBL] [Abstract][Full Text] [Related]
15. Inhibins/activins as diagnostic markers for ovarian cancer.
Robertson DM; Stephenson T; Pruysers E; Burger HG; McCloud P; Tsigos A; Groome N; Mamers P; McNeilage J; Jobling T; Healy D
Mol Cell Endocrinol; 2002 May; 191(1):97-103. PubMed ID: 12044923
[TBL] [Abstract][Full Text] [Related]
16. Inhibin concentrations in mares with granulosa cell tumors.
Bailey MT; Troedsson MH; Wheato JE
Theriogenology; 2002 Apr; 57(7):1885-95. PubMed ID: 12041692
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of inhibin in granulosa cell tumors of the ovary.
Jobling T; Mamers P; Healy DL; MacLachlan V; Burger HG; Quinn M; Rome R; Day AJ
Gynecol Oncol; 1994 Nov; 55(2):285-9. PubMed ID: 7959297
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A
Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252
[TBL] [Abstract][Full Text] [Related]
19. Inhibin as a marker for granulosa-cell tumors.
Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M; de Bruijn HW
N Engl J Med; 1989 Sep; 321(12):790-3. PubMed ID: 2770810
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
